Heart Disease News and Research

Latest Heart Disease News and Research

Amgen reports that Phase 3 DESCARTES study for high cholesterol meets primary endpoint

Amgen today announced that the Phase 3 DESCARTES (Durable Effect of PCSK9 Antibody CompARed wiTh PlacEbo Study) study evaluating the long-term 52-week safety and efficacy of evolocumab for the treatment of high cholesterol met its primary endpoint of percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at week 52.

20 Dec 2013

Sugar-based gelators may provide alternatives to trans fats linked to obesity, heart disease, diabetes

Researchers at The City College of New York have reported the successful transformation of vegetable oils to a semisolid form using low-calorie sugars as a structuring agent.

20 Dec 2013

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

In a new study, scientists from University of Copenhagen document a connection between congenital arrhythmia and the bodies' ability to handle sugar. The results can be of vital importance for patients with the disease and for the future treatment of diabetes. The new study has just been published in the scientific journal Diabetes.

19 Dec 2013

Shared genetic risk for bipolar disorder and BMI

Researchers have found a positive association in the heritability of bipolar disorder and body mass index, supporting the theory that there is some interaction in the genetic mechanisms underlying these two traits.

19 Dec 2013

Head injuries increase risk for psychiatric disorders

A Danish study of a large cohort of individuals who presented at hospital with head injuries has found that they were at increased risk for later developing schizophrenia, bipolar disorder, depression, and organic mental disorders.

19 Dec 2013

COPD undertreatment widespread

A study has shown that undertreatment of chronic obstructive pulmonary disease is highly prevalent.

19 Dec 2013

Diet may not fully explain cardiometabolic problems in bipolar disorder

The diet of patients with bipolar disorder or schizophrenia seems to be no worse than that of mentally healthy people, a study suggests.

19 Dec 2013

MEDNAX acquires Neonatology Center of Winchester

MEDNAX, Inc., today announced the acquisition of Neonatology Center of Winchester, P.C., a neonatal physician group practice based in Winchester, Va. The practice will become part of MEDNAX's Pediatrix Medical Group division, a national group practice consisting of the nation's leading neonatal, maternal-fetal medicine, pediatric cardiology, and other pediatric specialty physicians.

19 Dec 2013

Daiichi Sankyo submits LIXIANA supplemental NDA for review in Japan

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has submitted a supplemental New Drug Application for its oral, once-daily direct factor Xa-inhibitor LIXIANA® (Edoxaban Tosilate Hydrate) for review by the Japanese Ministry of Health, Labour and Welfare. Daiichi Sankyo is seeking approval in Japan for edoxaban in new indications for non-valvular atrial fibrillation and symptomatic venous thromboembolism.

19 Dec 2013

Two GW professors named 2013 Fellows of the National Academy of Inventors

Ferid Murad and Akos Vertes-two of George Washington University's scientific pioneers-are among the 143 innovators who have been named 2013 Fellows of the National Academy of Inventors.

19 Dec 2013

Tryton Medical launches Bifurcation Institute to advance care for bifurcated coronary artery disease

Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced the launch of the Bifurcation Institute. The Bifurcation Institute is a comprehensive education resource established to advance the standard of care for bifurcated coronary artery disease, a common, and often untreated, clinical need.

19 Dec 2013

Inactive patients following cardiac surgery have higher risk of depression

New research indicates that inactive patients following cardiac surgery have a substantially higher risk of depression and that the number of patients suffering from depression after cardiac surgery is as high as 40%. Investigators recommend that cardiac patients should be assessed for depression and level of physical activity and remain as active as they safely can after surgery to minimize post-operative depression. The results are published in the December issue of the Canadian Journal of Cardiology.

19 Dec 2013

Randomized control trials to study clinical effectiveness of high dose flu vaccine in nursing homes

One of the highest risk groups for developing pneumonia or even dying from the flu is the elderly, especially in group settings such as nursing homes.

19 Dec 2013

Computer-controlled, rotating table could deliver high doses of radiotherapy to tumors, spare vulnerable organs

Swivelling patients around on a computer-controlled, rotating table could deliver high doses of radiotherapy to tumours more quickly than current methods, while sparing vulnerable organs such as the heart, brain, eyes and bowel.

19 Dec 2013

Poor people, minorities appear to suffer from sleep problems, chronic disease

Poor people and minorities appear to disproportionately suffer from problems with sleep and chronic disease, but the two do not appear to be directly linked, finds a new study in Ethnicity & Disease.

19 Dec 2013

New program to help older adults live healthier, more independent lives

University Hospitals (UH) Bedford Medical Center, a campus of UH Regional Hospitals, has launched a new program to help older adults live healthier, more independent lives.

19 Dec 2013

Sanofi and Regeneron Pharmaceuticals team up with ACC to enhance clinical research with alirocumab

Sanofi and Regeneron Pharmaceuticals, Inc. today announced an innovative collaboration with the American College of Cardiology focused on enhancing clinical research with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). PCSK9 is known to contribute to circulating low-density lipoprotein cholesterol (LDL-C) levels. Alirocumab is being co-developed by Sanofi and Regeneron.

19 Dec 2013

Heart Disease News and Research

Latest Heart Disease News and Research

Amgen reports that Phase 3 DESCARTES study for high cholesterol meets primary endpoint

Sugar-based gelators may provide alternatives to trans fats linked to obesity, heart disease, diabetes

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

Shared genetic risk for bipolar disorder and BMI

Head injuries increase risk for psychiatric disorders

COPD undertreatment widespread

Diet may not fully explain cardiometabolic problems in bipolar disorder

MEDNAX acquires Neonatology Center of Winchester

Daiichi Sankyo submits LIXIANA supplemental NDA for review in Japan

Two GW professors named 2013 Fellows of the National Academy of Inventors

Tryton Medical launches Bifurcation Institute to advance care for bifurcated coronary artery disease

Inactive patients following cardiac surgery have higher risk of depression

Randomized control trials to study clinical effectiveness of high dose flu vaccine in nursing homes

Computer-controlled, rotating table could deliver high doses of radiotherapy to tumors, spare vulnerable organs

Poor people, minorities appear to suffer from sleep problems, chronic disease

New program to help older adults live healthier, more independent lives

Sanofi and Regeneron Pharmaceuticals team up with ACC to enhance clinical research with alirocumab

Researchers investigate several non-invasive methods for measuring intracranial pressure

Study reveals why people are predisposed to cardiovascular disease and death

New guideline to help doctors treat patients with hypertension

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in